1. Home
  2. CASY vs RPRX Comparison

CASY vs RPRX Comparison

Compare CASY & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Casey's General Stores Inc.

CASY

Casey's General Stores Inc.

HOLD

Current Price

$658.17

Market Cap

24.5B

Sector

Miscellaneous

ML Signal

HOLD

Logo Royalty Pharma plc

RPRX

Royalty Pharma plc

HOLD

Current Price

$45.31

Market Cap

19.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASY
RPRX
Founded
1959
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.5B
19.7B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
CASY
RPRX
Price
$658.17
$45.31
Analyst Decision
Buy
Strong Buy
Analyst Count
11
4
Target Price
$667.18
$47.75
AVG Volume (30 Days)
374.7K
2.8M
Earning Date
03-09-2026
05-07-2026
Dividend Yield
0.34%
2.06%
EPS Growth
9.01
N/A
EPS
14.79
1.78
Revenue
$15,940,899,000.00
$2,378,193,000.00
Revenue This Year
$10.63
$38.30
Revenue Next Year
$5.36
$4.80
P/E Ratio
$44.95
$25.55
Revenue Growth
7.25
5.06
52 Week Low
$397.80
$29.66
52 Week High
$694.93
$47.86

Technical Indicators

Market Signals
Indicator
CASY
RPRX
Relative Strength Index (RSI) 47.56 50.40
Support Level $540.43 $44.94
Resistance Level $684.33 $46.14
Average True Range (ATR) 20.56 0.84
MACD -3.69 -0.27
Stochastic Oscillator 45.27 18.37

Price Performance

Historical Comparison
CASY
RPRX

About CASY Casey's General Stores Inc.

Casey's General Stores Inc serves as convenience store chain with its 2,900 locations, positioned in the Midwest United States. About half of Casey's stores are located in rural towns with populations under 5,000. While fueling stations serve as a key traffic driver, about two-thirds of the company's gross profit stems from in-store sales of grocery items, prepared meals, and general merchandise. Casey's owns more than 90% of its stores and operates the majority of its warehousing and distribution processes internally.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: